Health

Documento de Investigación 85, Mayo 2018

Acceso a medicamentos: experiencias con licencias obligatorias y uso gubernamental – el caso de la Hepatitis C

El acceso a medicamentos está fuertemente condicionado por su precio y por los mecanismos de financiamiento que pueden aplicarse en cada país. […] Un factor determinante en la fijación del precio de los medicamentos es el grado de competencia existente en una particular clase terapéutica, la que a su vez es influenciada por la existencia o no de derechos de propiedad intelectual, como patentes de invención.

(more…)

SC Lunch Briefing with the Executive Director, 17 April 2018

Title:                 The Global South Facing a New Era of Unilateralism and Protectionism: Challenges and                                            Prospects

Date:                 Tuesday, 17 April 2018, 13h00-15h00

Venue:              Room XXIII, Palais des Nations, Geneva

Organizers:      The South Centre

(more…)

Statement, May 2018

South Centre Statement at the Meeting of Ministers of Health of the Member States of the Non-Aligned Movement

The South Centre reiterates its commitment to support the Non-Aligned countries so that there is close and effective cooperation among developing countries to strengthen a global health agenda. WHO was created as an international public agency in the service of global health. Recovering and reinforcing this role should be the work of all.

(more…)

South Bulletin 101, 18 April 2018

AMR: The gravest threat to global health

Antibiotic resistance—and the broader antimicrobial resistance (AMR) – is a silent but major killer. In fact it is emerging as the most serious threat to global health, with experts warning of a “post-antibiotics apocalypse”.

This special issue of South Bulletin focuses on the AMR crisis, especially on how it affects developing countries—and the great challenges on fighting this threat.

(more…)

IP Negotiations Monitor 24, April 2018

The IP Negotiations Monitor summarizes the latest developments in multilateral and regional fora where intellectual property negotiations are taking place, and informs on upcoming meetings and events.

(Covering period: January – March 2018)

(more…)

Policy Brief 46, March 2018

Outcomes of the 142nd session of the WHO Executive Board

The 142nd session of the WHO Executive Board discussed several critical public health issues including a recommendation to the WHA to approve the General Program of Work (GPW), the adoption of important decisions relating to access to medicines and research and development and a draft resolution on the preparation of the UN High Level Meeting on Tuberculosis.

(more…)


0

Your Cart